Skip to content

    Recently Viewed


      Meet Fred Kilmer: One of Johnson & Johnson’s earliest pioneers

      The company’s first scientific director was responsible for groundbreaking innovations that surgeons use to this day. But there’s a lot more to this Renaissance man’s impressive story.

      Share Article
      share to
      Fred Kilmer Sepia 1640

      Fred Kilmer

      Image courtesy Johnson & Johnson archives

      When brothers James Wood Johnson and Edward Mead Johnson founded Johnson & Johnson 130 years ago with just 14 employees, they probably never dreamed that the company would expand to include 129,000 people working in 60 countries.

      In our new series, “Employee Blast from the Past,” we’ll chronicle the impact that some of Johnson & Johnson’s most remarkable staffers have had on the organization, the healthcare industry and, in some cases, the world.

      To kick it off, we’re celebrating a pharmacist who played a crucial role in building the company into the scientific powerhouse it is today—so much so that he’s the namesake of Kilmer House, a historical blog that documents Johnson & Johnson’s early days.

      The Employee …
      Fred Kilmer, Director of Scientific Affairs, 1889-1934

      Why He’s So Legendary …
      Kilmer—who would have turned 165 this month—began his career as a retail pharmacist, but he found his true calling in promoting antiseptic wound care and sterilization procedures to minimize the risk of infection during surgery—concepts that were revolutionary at the time.

      In addition to creating the groundbreaking Modern Methods of Antiseptic Wound Treatment publication, he established Johnson & Johnson’s Aseptic Department—introducing the idea of “clean rooms” for manufacturing sterile surgical dressings and sutures—and helped design new company buildings to accommodate innovative large steam sterilizers.But that’s not all.

      In addition to his scientific chops, Kilmer was a master of communication, serving as Johnson & Johnson’s Chief Publicity Officer who oversaw advertising and outreach to doctors, pharmacists and the public.

      The Renaissance man also gave birth to what ultimately became Johnson & Johnson’s iconic baby business by developing products to help soothe skin irritated from using medicated plasters.

      Tom Rutgers: Fred Kilmer's cat 590x400

      Kilmer’s cat, Tom Rutgers

      Image courtesy Johnson & Johnson archives

      What Most People Don’t Know …
      Kilmer was an inveterate animal lover. He had three cats—one of whom made it onto the pages of Johnson & Johnson’s publication for retail pharmacists that Kilmer edited, The Red Cross Messenger, to help illustrate an article about the history of felines in drugstores. He even kept a pet alligator in his pharmacy, located across the street from Johnson & Johnson.

      When you’ve been innovating for over 135 years …

      Johnson & Johnson has a virtual museum where you can learn more fun facts about its rich history.

      More from Johnson & Johnson

      Blue latex-gloved hands holding a beaker filled with yellow liquid

      IBD rates are rising in communities of color. Can these innovators help?

      Scientists aren’t sure what’s behind the upward trend. That’s why Johnson & Johnson Innovation put out the call to address this troubling health disparity.
      DNA illustration genetic material

      Harnessing the human genome is the future of healthcare—and Johnson & Johnson is helping lead the way

      The company’s partnership with the largest human genome sequencing project in the world will increase scientists’ understanding of genetic diseases and help create new interventions. Here, a look at the breakthroughs that have guided the understanding of the power of DNA.
      Health & wellness
      1123 BTN-Lung Cancer-Iede2.jpg
      Health & wellness

      By the numbers: Who gets lung cancer?

      Each year, more people die of lung cancer than colon, breast and prostate cancers combined. Learn how Johnson & Johnson is dedicated to improving outcomes by integrating the company’s MedTech and Innovative Medicine expertise.
      You are now leaving and going to a site with a different privacy policy. Please click below to continue to that site.